Complicated Urinary Tract Infections Treatment Market

Future Market Insights

Key Insight

Demand for complicated urinary tract infections treatment will increase through 2036, with cephalosporin at 36.5% of the drug class segment in 2026. The market was valued at USD 10.3 million in 2025 and is expected to reach USD 19.8 million by 2036, creating an incremental opportunity of USD 8.8 million.

April 28, 2026

Anurag Sharma

299 Pages

Cite this Report

Complicated Urinary Tract Infections Treatment Market

https://www.futuremarketinsights.com/reports/complicated-urinary-tract-infections-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

The Vanguard Group
BlackRock
Cipla Ltd
Entasis Therapeutics
GlaxoSmithKline plc (GSK)
Merck KGaA
Shionogi & Co. Ltd
Venatorx Pharmaceuticals
Wockhardt Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Complicated Urinary Tract Infections Treatment Market

Key Players

Similar Industry Reports